| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Anti-PD-L1 atezolizumab-Induced Autoimmune Diabetes: a Case Report and Review of the Literature
|
Hickmott, Laura
|
|
2017
|
12 |
2 |
p. 235-241
|
article
|
| 2 |
Clinical Implications of Cytotoxic T Lymphocyte Antigen-4 Expression on Tumor Cells and Tumor-Infiltrating Lymphocytes in Extrahepatic Bile Duct Cancer Patients Undergoing Surgery Plus Adjuvant Chemoradiotherapy
|
Lim, Yu Jin
|
|
2017
|
12 |
2 |
p. 211-218
|
article
|
| 3 |
Erratum to: A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines
|
Shi, Yi
|
|
2017
|
12 |
2 |
p. 263
|
article
|
| 4 |
Exploiting microRNAs As Cancer Therapeutics
|
Robb, Tamsin
|
|
2017
|
12 |
2 |
p. 163-178
|
article
|
| 5 |
Immuno-Oncology: The Third Paradigm in Early Drug Development
|
Martin-Liberal, Juan
|
|
2016
|
12 |
2 |
p. 125-138
|
article
|
| 6 |
miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives
|
Florczuk, Mateusz
|
|
2017
|
12 |
2 |
p. 179-200
|
article
|
| 7 |
Obinutuzumab: A Review in Rituximab-Refractory or -Relapsed Follicular Lymphoma
|
Dhillon, Sohita
|
|
2017
|
12 |
2 |
p. 255-262
|
article
|
| 8 |
Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance)
|
Hubbard, Joleen M.
|
|
2016
|
12 |
2 |
p. 201-209
|
article
|
| 9 |
Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance)
|
Hubbard, Joleen M.
|
|
|
12 |
2 |
p. 201-209
|
article
|
| 10 |
Risk of Second Primary Malignancies in Lung Cancer Survivors – The Influence of Different Treatments
|
Su, Vincent Yi-Fong
|
|
2016
|
12 |
2 |
p. 219-227
|
article
|
| 11 |
Sorafenib: A Review in Hepatocellular Carcinoma
|
Keating, Gillian M.
|
|
2017
|
12 |
2 |
p. 243-253
|
article
|
| 12 |
Sorafenib: A Review in Hepatocellular Carcinoma
|
Keating, Gillian M.
|
|
|
12 |
2 |
p. 243-253
|
article
|
| 13 |
Splenic Enlargement and Bone Marrow Hyperplasia in Patients Receiving Trastuzumab-Emtansine for Metastatic Breast Cancer
|
Kosmin, Michael
|
|
2017
|
12 |
2 |
p. 229-234
|
article
|
| 14 |
The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities
|
Flynn, Nicole J.
|
|
2017
|
12 |
2 |
p. 139-152
|
article
|
| 15 |
Treatment Options for EGFR T790M-Negative EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer
|
Corallo, Salvatore
|
|
2017
|
12 |
2 |
p. 153-161
|
article
|
Journal description